Ireland based Jazz Pharmaceuticals plc has announced that the Phase 1 study of its recombinant crisantaspase molecu...
DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
